Malignant Head and Neck Neoplasm — Trials

Malignant Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,448 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,431
Recruiting: 781
Ph III recruiting: 109
Growth YoY: +20.1%
Industry share: 18%
Top sponsor: Sun Yat-sen University
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (629)

clinicaltrialsPublishedShowing 301–339 of 339 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05187338	Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors	recruiting	Phase 1 / Phase 2	100	Second Affiliated Hospital of Guangzhou Medical UniversityOTHER	1	Jun 25, 2024	clinicaltrials
NCT06455410	GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma	recruiting	Phase 2	216	Sun Yat-sen UniversityOTHER	1	Jun 25, 2024	clinicaltrials